Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
eplerenona cinfa
- Development stage
- Unknown
- Lead developer
- CINFA
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Eplerenona Cinfa is a generic pharmaceutical product containing the active ingredient eplerenone, a selective mineralocorticoid receptor antagonist (MRA). It functions by competitively inhibiting the binding of aldosterone to the mineralocorticoid receptor, particularly in the heart, blood vessels, and kidneys. This inhibition prevents the downstream effects of aldosterone, such as sodium retention, potassium excretion, and the promotion of inflammation and fibrosis in cardiovascular tissues. Clinically, eplerenone is used to improve survival in patients with symptomatic heart failure following a recent myocardial infarction and in those with chronic heart failure and reduced ejection fraction. The specific formulation Eplerenona Cinfa has been studied in clinical trials, including research sponsored by the Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia, to evaluate its potential benefits in patients with non-ischemic dilated cardiomyopathy.
- Brand names
- Eplerenona Cinfa
- Other names
- eplerenone cinfa
02
Targets
MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on eplerenona cinfa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eplerenona cinfa.